Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0GN3M
|
||||
Former ID |
DNC005597
|
||||
Drug Name |
Ala11-SRIF-14-amide
|
||||
Indication | Discovery agent | Investigative | [527585] | ||
Structure |
Download2D MOL |
||||
Formula |
C70H101N19O18S2
|
||||
Canonical SMILES |
CC1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)N<br />C(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)C(C)O)CCCCN)C<br />C2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=CC=CC=C5)CC(=O)N)CCC<br />CN)NC(=O)CNC(=O)C(C)N)C(=O)N)CO)C(C)O
|
||||
InChI |
1S/C70H101N19O18S2/c1-36(73)59(96)77-32-55(94)79-53-35-109-108-34-52(58(75)95)87-67(104)51(33-90)86-70(107)57(39(4)92)88-60(97)37(2)78-69(106)56(38(3)91)89-62(99)46(24-14-16-26-72)80-65(102)49(29-42-31-76-44-22-12-11-21-43(42)44)84-64(101)48(28-41-19-9-6-10-20-41)82-63(100)47(27-40-17-7-5-8-18-40)83-66(103)50(30-54(74)93)85-61(98)45(81-68(53)105)23-13-15-25-71/h5-12,17-22,31,36-39,45-53,56-57,76,90-92H,13-16,23-30,32-35,71-73H2,1-4H3,(H2,74,93)(H2,75,95)(H,77,96)(H,78,106)(H,79,94)(H,80,102)(H,81,105)(H,82,100)(H,83,103)(H,84,101)(H,85,98)(H,86,107)(H,87,104)(H,88,97)(H,89,99)/t36-,37-,38?,39?,45-,46+,47-,48+,49-,50+,51-,52-,53-,56+,57+/m0/s1
|
||||
InChIKey |
DWTUVBZITHQYDR-CFWAKGAOSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Somatostatin receptor type 2 | Target Info | Inhibitor | [527585] | |
Somatostatin receptor type 4 | Target Info | Inhibitor | [527585] | ||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
PathWhiz Pathway | Gastric Acid Production | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.